GPI attending the World Orphan Drug Congress

14-17 November 2022, Sitges, Barcelona, Spain

GPI will be attending the World Orphan Drug congress, held in Sitges, Barcelona, Spain on 14-17 November 2022. Our representatives will be onsite and on hand to discuss how GPI can optimise your pricing and market access decision-making in 2022, 2023 and beyond. The conference, together with the co-located Cell & Gene Therapy Congress, will continue to bring experts from the whole value chain under one roof, where you get to meet decision makers in the areas that are most applicable for your business offering.

Key Programme Sessions of 2022:

The conference looks to cover all the important topics, including:

  • Cell & Gene Therapies
  • Genetic Testing
  • Gene Editing
  • Partnering & Investment
  • Global Market Access
  • Expanded Access Programs
  • Real World Evidence
  • Global Patient Advocacy
  • Value Based Pricing & Reimbursement
  • Epidemiology & Forecasting
  • Orphan Drugs Policy
  • Gene Therapy Development
  • Clinical Trials
  • Payers, HTA and Pricing
  • Manufacture

You will be able to discuss pricing and market access challenges, stakeholder relationships discover innovative tools and solutions for the ecosystem. Most notably, GPI’s innovative suite of technological and service-based solutions, GPI pulse™ data analytics platform, and GPI horizon, a unique platform solution, based on our award-winning methodology that quantifies an asset’s position in the market.

GPI at the World Orphan Drug Congress

Book a meeting with us to talk about our GPI horizon, our unique platform solution, based on our award-winning methodology, that quantifies an asset’s position in the market – from a clinical, price, and payer perspective.

In addition, find out how we utilise data from GPI pulse™ for value, price, and market access insight. The award-winning platform is designed to be used as part of GPI’s comprehensive solution for pharma pricing and market access strategy, but can also be used to create efficient, robust insights as a standalone data analytics tool.

Featured image WODC 22

Share the Article:

Sign up to our mailing list to be informed of the latest webinars